ZNF420 is a zinc finger protein with transcriptional regulatory function that binds DNA and regulates RNA polymerase II-dependent gene expression 1. The protein contains zinc finger domains enabling sequence-specific DNA binding and acts as a transcription factor in the nucleus and nucleoplasm. ZNF420 has emerged as a significant biomarker in cardiovascular and oncological contexts. During off-pump coronary artery bypass grafting, ZNF420 was identified as a cardioprotection-related biomarker, with pathway enrichment analysis revealing involvement in cell cycle and tricarboxylic acid cycle regulation 1. In head and neck squamous cell carcinoma, ZNF420 was selected among top zinc finger genes showing differential DNA methylation in tumors compared to normal tissues, demonstrating 100% specificity for cancer detection in primary tissue and saliva samples when combined with other methylation biomarkers 2. While direct functional studies of ZNF420 are limited in provided abstracts, its classification within the KRAB-type zinc finger protein family suggests potential roles in gene repression and stress response regulation, similar to related zinc finger proteins like Apak that regulate p53-mediated apoptosis and ribosomal biogenesis 34. ZNF420's utility as a clinical biomarker indicates its differential expression patterns may reflect important pathophysiological processes in cardiovascular and cancer contexts.